State Street’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Buy |
1,443,559
+923,379
| +178% | +$12.5M | ﹤0.01% | 2199 |
|
|
2025
Q1 | $8.26M | Buy |
520,180
+15,647
| +3% | +$248K | ﹤0.01% | 2651 |
|
|
2024
Q4 | $6.21M | Buy |
504,533
+20,767
| +4% | +$256K | ﹤0.01% | 2870 |
|
|
2024
Q3 | $5.86M | Buy |
483,766
+18,627
| +4% | +$226K | ﹤0.01% | 2888 |
|
|
2024
Q2 | $5.44M | Buy |
465,139
+159,453
| +52% | +$1.87M | ﹤0.01% | 2891 |
|
|
2024
Q1 | $3.95M | Buy |
305,686
+23,602
| +8% | +$305K | ﹤0.01% | 3019 |
|
|
2023
Q4 | $2.43M | Buy |
282,084
+52,107
| +23% | +$448K | ﹤0.01% | 3251 |
|
|
2023
Q3 | $2.19M | Buy |
229,977
+18,780
| +9% | +$179K | ﹤0.01% | 3289 |
|
|
2023
Q2 | $3.6M | Buy |
211,197
+76,397
| +57% | +$1.3M | ﹤0.01% | 3159 |
|
|
2023
Q1 | $2.11M | Buy |
+134,800
| New | +$2.11M | ﹤0.01% | 3321 |
|